The University of Chicago Header Logo

Connection

Justin P. Kline to Bortezomib

Back to Details
This is a "connection" page, showing publications Justin P. Kline has written about Bortezomib.
Justin P. Kline
Connection Strength
0.028
Bortezomib
  1. A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomas. Br J Haematol. 2013 Oct; 163(1):55-61.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.